Nicotine Metabolite Ratio Is Associated With Lozenge Use But Not Quitting in Smokeless Tobacco Users.

about

Nicotine Metabolite Ratio (NMR) Prospectively Predicts Smoking Relapse: Longitudinal Findings From ITC Surveys in Five Countries.Influence of Nicotine Metabolism Ratio on [11C]-(+)-PHNO PET binding in Tobacco Smokers.

P2860

Q46586422-962A8DE8-81C4-4FEE-8BD8-B2B6060BA136 Q47554488-AA18FF96-3F1F-4AF7-B4B8-9DE01C9F6FAA

P2860

Nicotine Metabolite Ratio Is Associated With Lozenge Use But Not Quitting in Smokeless Tobacco Users.

Item

http://www.wikidata.org/entity/Q40936765

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Nicotine Metabolite Ratio Is A ...... ng in Smokeless Tobacco Users.

@en

type

Item

label

Nicotine Metabolite Ratio Is A ...... ng in Smokeless Tobacco Users.

@en

prefLabel

Nicotine Metabolite Ratio Is A ...... ng in Smokeless Tobacco Users.

@en

P1476

Nicotine Metabolite Ratio Is A ...... ing in Smokeless Tobacco Users

@en

P2093

Darrell R Schroeder

http://www.w3.org/2001/XMLSchema#string

Herbert H Severson

http://www.w3.org/2001/XMLSchema#string

Jon O Ebbert

http://www.w3.org/2001/XMLSchema#string

Neal L Benowitz

http://www.w3.org/2001/XMLSchema#string

P2860

Interventions for smokeless tobacco use cessation

Nicotine chemistry, metabolism, kinetics and biomarkers

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans.

Genetic and environmental influences on the ratio of 3'hydroxycotinine to cotinine in plasma and urine

Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers

Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.

CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people

A comparison of three smokeless tobacco dependence measures

Alaska Native smokers and smokeless tobacco users with slower CYP2A6 activity have lower tobacco consumption, lower tobacco-specific nitrosamine exposure and lower tobacco-specific nitrosamine bioactivation.

P304

366-370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NTR/NTV102

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Brian G Danaher

P577

2015-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25977408

http://www.w3.org/2001/XMLSchema#string

P932

6095223

http://www.w3.org/2001/XMLSchema#string

6095227

http://www.w3.org/2001/XMLSchema#string

Nicotine Metabolite Ratio Is Associated With Lozenge Use But Not Quitting in Smokeless Tobacco Users.

about

P2860

P2860

Nicotine Metabolite Ratio Is Associated With Lozenge Use But Not Quitting in Smokeless Tobacco Users.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932